A study found that daily avocado consumption of about one whole, medium avocado per day improves the gut microbiome. Avocado ...

The largest survey yet to examine seriously ill patients receiving charitable copayment assistance found high out-of-pocket costs impact access to health care, adherence to medication, and quality of ...

Excess fat influences lipoprotein levels ... The controversy over a specific definition of MetSyn has complicated both clinical and genetic studies, and raises the question of whether there ...

In addition, a number of ALLHAT participants (n=10,337) participated in a randomized, open-label trial designed to determine whether lowering low-density lipoprotein cholesterol with the HMG-CoA ...

Cynthia Sass is a nutritionist and registered dietitian with master's degrees in both nutrition science and public health. Frequently seen on national TV, she's Health's contributing nutrition ...

After integrating the clinical definition and RCS-selected knots ... distinguishable sets of OSA risk factors were quantified: low-density lipoprotein cholesterol (LDL-C), apolipoprotein E and ...

For hyperlipidemia definitions, only four studies provided specific criteria, whereas the other five used a generalized definition without distinguishing between low-density lipoprotein cholesterol ...

The definition of dyslipidemia was based on the National Cholesterol ... BMI, body mass index; CRP, C-reactive protein; CVD, cardiovascular disease; HDL-C, high-density lipoprotein cholesterol; LDL-C, ...

Low-density lipoprotein cholesterol was calculated using the Friedewald ... men n=534 and women n=485), and comprised the working sample of this work. The definition of the investigated outcomes was ...

A small amount variance explained by the genetic variant(s) does not hamper the conclusions that can be drawn from a Mendelian randomisation study, but it does have implications, however, for ...

Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. The safety and efficacy of lepodisiran, an extended-duration, small interfering RNA targeting ...

The phase 2 trial tested the effect of lepodisiran on lipoprotein(a) (Lp(a)). Studies suggest up to 2 billion people globally have elevated Lp(a), which is associated with cardiovascular disease ...